Other specified degenerative diseases of basal ganglia
ICD-10 G23.8 is a billable code used to indicate a diagnosis of other specified degenerative diseases of basal ganglia.
G23.8 encompasses a variety of degenerative diseases affecting the basal ganglia, which are critical for coordinating movement and regulating motor control. This category includes conditions that do not fit neatly into other specified categories, such as atypical parkinsonism or other movement disorders that may present with symptoms similar to Parkinson's disease but have distinct underlying pathophysiologies. Patients may exhibit a range of symptoms including bradykinesia, rigidity, tremors, and postural instability. The basal ganglia's role in the extrapyramidal system means that these disorders can also lead to non-motor symptoms such as cognitive decline, mood disorders, and autonomic dysfunction. Treatment often involves dopaminergic medications, which aim to alleviate motor symptoms by enhancing dopaminergic activity in the brain. However, the response to treatment can vary significantly among patients, necessitating careful monitoring and adjustment of therapy. Accurate coding is essential for appropriate management and reimbursement, as these conditions can be complex and multifaceted.
Detailed neurological examination findings, including motor and non-motor symptoms, and response to treatment.
Diagnosis of atypical parkinsonism, management of movement disorders, and evaluation of treatment efficacy.
Neurologists should ensure that all symptoms, including cognitive and mood changes, are documented to support the diagnosis.
Comprehensive assessment of functional status, cognitive function, and medication management.
Management of elderly patients with movement disorders and polypharmacy considerations.
Geriatricians should document the impact of the condition on daily living activities and any co-morbidities.
Used for follow-up visits for management of G23.8.
Document history of present illness, review of systems, and assessment of treatment response.
Neurologists should ensure that all relevant symptoms are documented.
Common symptoms include bradykinesia, rigidity, tremors, and non-motor symptoms such as cognitive decline and mood disorders.
G23.8 is used when the degenerative disease does not meet the criteria for Parkinson's disease, which is specifically coded under G20.
